Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent: Staten Island, New York Thursday, February 20, 2025, 18:00 Hrs [IST] Acurx Pharmaceuticals, Inc., ...
The Society for Clinical Research Sites (SCRS) and Fortrea , a leading global contract research organization (CRO), are pleased to announce Fortrea's sponsorship of the SCRS Collaborate Forward ...
The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
In a look ahead at a week of Cambridge and Somerville events, Foundry Fest, a “Not Dead Yet!” tribute to Tom Lehrer, gospel ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback